aiNET
About
aiNET, an ETH spin-off, is an informatics and biotechnology company at the forefront of immune system innovation, bridging diagnostics and therapeutics through advanced TCR and BCR biomarker discovery using artificial intelligence.
We unlock immune signatures to guide prevention, early diagnostics and guide the potential development of targeted therapeutics like antibodies, vaccines and engineered of CAR T cells. Our integrated approach transforms immune profiling into a powerful engine for therapeutic innovation, accelerating the path from immune insight to clinical impact.
Target Markets of your organization / Expansion or target markets of your spin-off
Covered funding stages of your organization / Spin-off Funding Stage
Industry Sector your organization invests in / Industry Sector of your Spin-off
Representatives
Professor
aiNET